TY  - GEN
AU  - Sharma,Sanjay
AU  - Johnson,Davin
AU  - Abouammoh,Marwan
AU  - Hollands,Simon
AU  - Brissette,Ashley
TI  - Rate of serious adverse effects in a series of bevacizumab and ranibizumab injections
SN  - 1715-3360
PY  - 2012///0816
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Bevacizumab
KW  - Endophthalmitis
KW  - epidemiology
KW  - Female
KW  - Humans
KW  - Intravitreal Injections
KW  - Macular Edema
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Ranibizumab
KW  - Retinal Detachment
KW  - Retinal Vein Occlusion
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Thromboembolism
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - Visual Acuity
KW  - Vitreous Hemorrhage
KW  - Wet Macular Degeneration
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jcjo.2012.03.026
ER  -